American pharmaceutical company «Vivus» received positive FDA decision on application for approval of new erectile dysfunction drug «Stendra». Over the past ten years, Stendra drug was the first registered drug for this disease treatment. The new drug is a selective phosphodiesterase type 5 (PDE-5) inhibitor. Its active substance – avanafil – increases blood flow and […]